Argenx, NL0010832176

Argenx stock heads into the open after a 0.39 percent drop

Published on 09/23/2026 at 08:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 21, 2026, Argenx stock stood at EUR 868.00 in Brussels after falling 0.39 percent, with 53,352 shares traded. The next quarterly results are scheduled for October 22, 2026.

Fotorealistisches Laborpanorama: Wissenschaftler in weißen Kitteln begutachten leuchtende Antikörper-3D-Modelle auf Bildschirmen, Stahltische mit Laborgeräten im Hintergrund
Argenx NL0010832176 Forscher analysieren im modernen Biopharma-Labor leuchtende Antikörper-Strukturen auf großen Monitoren, Illustration mit AI erstellt.

Argenx stock closed at EUR 868.00 on Euronext Brussels on September 21, 2026, down 0.39 percent. The shares traded 53,352 units, while the BEL 20 closed at 5,763.48 points, up 0.88 percent on the same session.

September 21, 2026 in numbers

argenx SE (ISIN NL0010832176, Euronext Brussels: ARGX) recorded a weekly performance of 0.02 percent as of September 21, 2026, and a year-to-date gain of 21.09 percent. The close was EUR 57.00 below the one-year high of EUR 925.00 and EUR 299.60 above the one-year low of EUR 568.40.

The next quarterly results are scheduled for October 22, 2026, according to MarketScreener.

September 23, 2026 outlook

The European market session is the immediate trading context today. Preliminary manufacturing and services purchasing managers indexes for France, Germany, and the euro area are scheduled on September 23, 2026, followed later by United States data, according to TechFlow. These releases can affect biotechnology shares through broader European and United States risk sentiment.

Disclaimer...

en | NL0010832176 | ARGENX | boerse | 70163558 | bgmi